These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9440752)

  • 21. A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.
    Leão R; Nayan M; Punjani N; Jewett MAS; Fadaak K; Garisto J; Lewin J; Atenafu EG; Sweet J; Anson-Cartwright L; Boström P; Chung P; Warde P; Bedard PL; Bagrodia A; Freifeld Y; Power N; Winquist E; Hamilton RJ
    Eur Urol Focus; 2018 Dec; 4(6):995-1001. PubMed ID: 29428550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.
    Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Bajorin DF; Donohue JP; Habbema JD
    Br J Cancer; 1996 Nov; 74(9):1492-8. PubMed ID: 8912551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polytomous logistic regression analysis could be applied more often in diagnostic research.
    Biesheuvel CJ; Vergouwe Y; Steyerberg EW; Grobbee DE; Moons KG
    J Clin Epidemiol; 2008 Feb; 61(2):125-34. PubMed ID: 18177785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Growing teratoma syndrome].
    Urruchi Fernández P; Cavero Rebollo O; Jiménez Mas JA; Martínez Bengoechea J; González Enguita C; Rioja Sanz LA
    Actas Urol Esp; 1991; 15(2):205-8. PubMed ID: 1807117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
    Qvist HL; Fosså SD; Ous S; Høie J; Stenwig AE; Giercksky KE
    J Urol; 1991 Feb; 145(2):300-2; discussion 302-3. PubMed ID: 1988722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
    Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy.
    Dexeus FH; Shirkhoda A; Logothetis CJ; Chong C; Sella A; Ogden S; Swanson D
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):35-43. PubMed ID: 2920767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.
    Vergouwe Y; Steyerberg EW; Foster RS; Sleijfer DT; Fosså SD; Gerl A; de Wit R; Roberts JT; Habbema JD
    Eur Urol; 2007 Feb; 51(2):424-32. PubMed ID: 16911854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
    Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
    Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients.
    Vergouwe Y; Steyerberg EW; de Wit R; Roberts JT; Keizer HJ; Collette L; Stenning SP; Habbema JD
    Br J Cancer; 2003 Mar; 88(6):843-7. PubMed ID: 12644820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancer.
    Paffenholz P; Nestler T; Hoier S; Pfister D; Hellmich M; Heidenreich A
    Urol Oncol; 2019 Nov; 37(11):809.e9-809.e18. PubMed ID: 31540832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?
    Aide N; Comoz F; Sevin E
    J Clin Oncol; 2007 Oct; 25(28):4494-6. PubMed ID: 17906212
    [No Abstract]   [Full Text] [Related]  

  • 34. Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
    Carver BS; Bianco FJ; Shayegan B; Vickers A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Urol; 2006 Jul; 176(1):100-3; discussion 103-4. PubMed ID: 16753380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
    Stomper PC; Jochelson MS; Garnick MB; Richie JP
    AJR Am J Roentgenol; 1985 Oct; 145(4):743-6. PubMed ID: 3875994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
    Matsuzaki M; Nakano M; Komatsu H; Ohashi K
    Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study.
    Miranda Ede P; Abe DK; Nesrallah AJ; dos Reis ST; Crippa A; Srougi M; Dall'Oglio MF
    World J Surg Oncol; 2012 Sep; 10():203. PubMed ID: 23021209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
    Steyerberg EW; Keizer HJ; Zwartendijk J; Van Rijk GL; Van Groeningen CJ; Habbema JD; Stoter G
    Br J Cancer; 1993 Jul; 68(1):195-200. PubMed ID: 8318413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
    Toner GC; Panicek DM; Heelan RT; Geller NL; Lin SY; Bajorin D; Motzer RJ; Scher HI; Herr HW; Morse MJ
    J Clin Oncol; 1990 Oct; 8(10):1683-94. PubMed ID: 2170590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growing teratoma syndrome.
    Tongaonkar HB; Deshmane VH; Dalal AV; Kulkarni JN; Kamat MR
    J Surg Oncol; 1994 Jan; 55(1):56-60. PubMed ID: 8289455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.